188 related articles for article (PubMed ID: 37998351)
1. Transcriptome Changes in Glioma Cells upon Infection with the Oncolytic Virus VV-GMCSF-Lact.
Semenov DV; Vasileva NS; Dymova MA; Mishinov SV; Savinovskaya YI; Ageenko AB; Dome AS; Zinchenko ND; Stepanov GA; Kochneva GV; Richter VA; Kuligina EV
Cells; 2023 Nov; 12(22):. PubMed ID: 37998351
[TBL] [Abstract][Full Text] [Related]
2. The Recombinant Oncolytic Virus VV-GMCSF-Lact and Chemotherapy Drugs against Human Glioma.
Vasileva N; Ageenko A; Byvakina A; Sen'kova A; Kochneva G; Mishinov S; Richter V; Kuligina E
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673835
[TBL] [Abstract][Full Text] [Related]
3. Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy.
Kochneva G; Sivolobova G; Tkacheva A; Grazhdantseva A; Troitskaya O; Nushtaeva A; Tkachenko A; Kuligina E; Richter V; Koval O
Oncotarget; 2016 Nov; 7(45):74171-74188. PubMed ID: 27708236
[TBL] [Abstract][Full Text] [Related]
4. Characterizing Aptamer Interaction with the Oncolytic Virus VV-GMCSF-Lact.
Dymova MA; Malysheva DO; Popova VK; Dmitrienko EV; Endutkin AV; Drokov DV; Mukhanov VS; Byvakina AA; Kochneva GV; Artyushenko PV; Shchugoreva IA; Rogova AV; Tomilin FN; Kichkailo AS; Richter VA; Kuligina EV
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398600
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells.
Koval O; Kochneva G; Tkachenko A; Troitskaya O; Sivolobova G; Grazhdantseva A; Nushtaeva A; Kuligina E; Richter V
Biomed Res Int; 2017; 2017():3620510. PubMed ID: 28951871
[TBL] [Abstract][Full Text] [Related]
6. Double Recombinant Vaccinia Virus: A Candidate Drug against Human Glioblastoma.
Vasileva N; Ageenko A; Dmitrieva M; Nushtaeva A; Mishinov S; Kochneva G; Richter V; Kuligina E
Life (Basel); 2021 Oct; 11(10):. PubMed ID: 34685455
[TBL] [Abstract][Full Text] [Related]
7. The Signaling Pathways Controlling the Efficacy of Glioblastoma Therapy.
Vasileva NS; Ageenko AB; Richter VA; Kuligina EV
Acta Naturae; 2022; 14(2):62-70. PubMed ID: 35923561
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing.
Inoue T; Byrne T; Inoue M; Tait ME; Wall P; Wang A; Dermyer MR; Laklai H; Binder JJ; Lees C; Hollingsworth R; Maruri-Avidal L; Kirn DH; McDonald DM
Mol Cancer Ther; 2021 Aug; 20(8):1481-1494. PubMed ID: 34045231
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT).
Zuo S; Wei M; He B; Chen A; Wang S; Kong L; Zhang Y; Meng G; Xu T; Wu J; Yang F; Zhang H; Wang S; Guo C; Wu J; Dong J; Wei J
EBioMedicine; 2021 Feb; 64():103240. PubMed ID: 33581644
[TBL] [Abstract][Full Text] [Related]
10. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
Deng L; Fan J; Guo M; Huang B
Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
[TBL] [Abstract][Full Text] [Related]
11. Replication-deficient vaccinia virus gene therpay vector: evaluation of exogenous gene expression mediated by PUV-inactivated virus in glioma cells.
Timiryasova TM; Chen B; Fodor I
J Gene Med; 2001; 3(5):468-77. PubMed ID: 11601760
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Strains of Oncolytic Vaccinia Virus for Cancer Immunotherapy.
Shakiba Y; Vorobyev PO; Mahmoud M; Hamad A; Kochetkov DV; Yusubalieva GM; Baklaushev VP; Chumakov PM; Lipatova AV
Biochemistry (Mosc); 2023 Jun; 88(6):823-841. PubMed ID: 37748878
[TBL] [Abstract][Full Text] [Related]
13. An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade.
Zuo S; Wei M; Xu T; Kong L; He B; Wang S; Wang S; Wu J; Dong J; Wei J
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34949694
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of vaccinia virus in glioma model.
Timiryasova TM; Li J; Chen B; Chong D; Langridge WH; Gridley DS; Fodor I
Oncol Res; 1999; 11(3):133-44. PubMed ID: 10527073
[TBL] [Abstract][Full Text] [Related]
15. Identification of oncolytic vaccinia restriction factors in canine high-grade mammary tumor cells using single-cell transcriptomics.
Cambien B; Lebrigand K; Baeri A; Nottet N; Compin C; Lamit A; Ferraris O; Peyrefitte CN; Magnone V; Henriques J; Zaragosi LE; Giorgetti-Peraldi S; Bost F; Gautier-Isola M; Rezzonico R; Barbry P; Barthel R; Mari B; Vassaux G
PLoS Pathog; 2020 Oct; 16(10):e1008660. PubMed ID: 33075093
[TBL] [Abstract][Full Text] [Related]
16. Microglia and astrocytes attenuate the replication of the oncolytic vaccinia virus LIVP 1.1.1 in murine GL261 gliomas by acting as vaccinia virus traps.
Kober C; Rohn S; Weibel S; Geissinger U; Chen NG; Szalay AA
J Transl Med; 2015 Jul; 13():216. PubMed ID: 26149494
[TBL] [Abstract][Full Text] [Related]
17. GMCSF-armed vaccinia virus induces an antitumor immune response.
Parviainen S; Ahonen M; Diaconu I; Kipar A; Siurala M; Vähä-Koskela M; Kanerva A; Cerullo V; Hemminki A
Int J Cancer; 2015 Mar; 136(5):1065-72. PubMed ID: 25042001
[TBL] [Abstract][Full Text] [Related]
18. An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment.
Kostova Y; Mantwill K; Holm PS; Anton M
Cancer Gene Ther; 2015 Jan; 22(1):30-43. PubMed ID: 25501992
[TBL] [Abstract][Full Text] [Related]
19. Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors.
Pesonen S; Diaconu I; Cerullo V; Escutenaire S; Raki M; Kangasniemi L; Nokisalmi P; Dotti G; Guse K; Laasonen L; Partanen K; Karli E; Haavisto E; Oksanen M; Karioja-Kallio A; Hannuksela P; Holm SL; Kauppinen S; Joensuu T; Kanerva A; Hemminki A
Int J Cancer; 2012 Apr; 130(8):1937-47. PubMed ID: 21630267
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic vaccinia virus inhibits human hepatocellular carcinoma MHCC97-H cell proliferation via endoplasmic reticulum stress, autophagy and Wnt pathways.
Jia X; Chen Y; Zhao X; Lv C; Yan J
J Gene Med; 2016 Sep; 18(9):211-9. PubMed ID: 27441866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
